Significantly more patients with acute ischemic stroke achieved primary outcome of 0 or 1 on modified Rankin scale at 90 days ...
For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...
For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...
Remedy Pharmaceuticals, a leader in stroke drug development today announced efficacy data from the Phase 2 GAMES-RP and Phase 3 CHARM studies of CIRARA (intravenous glyburide) for the treatment of ...
Transplantation of neural stem cells improved neurologic and motor function for adults with chronic ischemic stroke at 12 ...
In a recent study evaluating the impact of coma duration on functional outcomes and long-term survival after cardiac arrest, ...
Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.
Hypertension, atrial fibrillation, and smoking are strongly associated with an increased risk for severe vs nonsevere stroke.
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback